Opaleye Management Inc. - AUDENTES THERAPEUTICS INC ownership

AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of AUDENTES THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$17,473,000
+118.2%
292,000
+2.5%
3.43%
+18.4%
Q3 2019$8,006,000
-24.5%
285,000
+1.8%
2.90%
-10.4%
Q2 2019$10,601,000
-3.0%
280,0000.0%3.23%
+6.8%
Q1 2019$10,926,000
+105.0%
280,000
+12.0%
3.02%
+52.1%
Q4 2018$5,330,000
-40.2%
250,000
+11.1%
1.99%
-12.2%
Q3 2018$8,907,000
+22.7%
225,000
+18.4%
2.27%
+20.6%
Q2 2018$7,259,000
+27.2%
190,0000.0%1.88%
+15.1%
Q1 2018$5,709,000
-14.2%
190,000
-9.5%
1.63%
-23.4%
Q4 2017$6,652,000
+32.0%
210,000
+16.7%
2.13%
+19.5%
Q3 2017$5,041,000
+75.7%
180,000
+20.0%
1.78%
+48.8%
Q2 2017$2,869,000150,0001.20%
Other shareholders
AUDENTES THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 767,502$45,927,00023.65%
Chicago Capital Management, LLC 250,401$14,984,00012.57%
Foresite Capital Management III, LLC 233,067$13,947,0007.82%
Partner Investment Management, L.P. 17,795$1,065,0007.65%
RAMIUS ADVISORS LLC 220,784$13,212,0005.68%
Beryl Capital Management LLC 550,426$32,937,0005.31%
GARDNER LEWIS ASSET MANAGEMENT L P 647,460$38,744,0005.28%
FNY Investment Advisers, LLC 278,861$16,687,0005.17%
WHITE SQUARE CAPITAL LLP 112,500$6,732,0004.87%
Casdin Capital, LLC 860,000$51,462,0004.73%
View complete list of AUDENTES THERAPEUTICS INC shareholders